Folgen
Alain Beck
Alain Beck
Centre d'Immunologie Pierre Fabre
Bestätigte E-Mail-Adresse bei pierre-fabre.com
Titel
Zitiert von
Zitiert von
Jahr
Strategies and challenges for the next generation of antibody–drug conjugates
A Beck, L Goetsch, C Dumontet, N Corvaïa
Nature reviews Drug discovery 16 (5), 315-337, 2017
18472017
Strategies and challenges for the next generation of therapeutic antibodies
A Beck, T Wurch, C Bailly, N Corvaia
Nature reviews immunology 10 (5), 345-352, 2010
10562010
Characterization of therapeutic antibodies and related products
A Beck, E Wagner-Rousset, D Ayoub, A Van Dorsselaer, ...
Analytical chemistry 85 (2), 715-736, 2013
6552013
Theory and practice of size exclusion chromatography for the analysis of protein aggregates
S Fekete, A Beck, JL Veuthey, D Guillarme
Journal of pharmaceutical and biomedical analysis 101, 161-173, 2014
3522014
Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry
A Beck, S Sanglier-Cianférani, A Van Dorsselaer
Analytical chemistry 84 (11), 4637-4646, 2012
3042012
Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins
A Beck, E Wagner-Rousset, MC Bussat, M Lokteff, C Klinguer-Hamour, ...
Current pharmaceutical biotechnology 9 (6), 482-501, 2008
3042008
A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor …
L Goetsch, A Gonzalez, O Leger, A Beck, PJ Pauwels, JF Haeuw, ...
International journal of cancer 113 (2), 316-328, 2005
2772005
Ion-exchange chromatography for the characterization of biopharmaceuticals
S Fekete, A Beck, JL Veuthey, D Guillarme
Journal of pharmaceutical and biomedical analysis 113, 43-55, 2015
2702015
Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody
J Vlasak, MC Bussat, S Wang, E Wagner-Rousset, M Schaefer, ...
Analytical biochemistry 392 (2), 145-154, 2009
2702009
Antibody–drug conjugates: The last decade
N Joubert, A Beck, C Dumontet, C Denevault-Sabourin
Pharmaceuticals 13 (9), 245, 2020
2572020
Marketing approval of mogamulizumab: a triumph for glyco-engineering
A Beck, JM Reichert
MAbs 4 (4), 419-425, 2012
2372012
Anti-IGF-IR antibodies and uses thereof
L Goetsch, N Corvaia, O Leger, A Duflos, JF Haeuw, A Beck
US Patent 7,241,444, 2007
216*2007
Structure, heterogeneity and developability assessment of therapeutic antibodies
Y Xu, D Wang, B Mason, T Rossomando, N Li, D Liu, JK Cheung, W Xu, ...
MAbs 11 (2), 239-264, 2019
2042019
Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry
L Fornelli, D Ayoub, K Aizikov, A Beck, YO Tsybin
Analytical chemistry 86 (6), 3005-3012, 2014
2012014
The next generation of antibody-drug conjugates comes of age
A Beck, JF Haeuw, T Wurch, L Goetsch, C Bailly, N Corvaïa
Discovery medicine 10 (53), 329-339, 2010
1962010
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry …
D Ayoub, W Jabs, A Resemann, W Evers, C Evans, L Main, C Baessmann, ...
MAbs 5 (5), 699-710, 2013
1932013
Innovative native MS methodologies for antibody drug conjugate characterization: high resolution native MS and IM-MS for average DAR and DAR distribution assessment
F Debaene, A Boeuf, E Wagner-Rousset, O Colas, D Ayoub, N Corvaia, ...
Analytical chemistry 86 (21), 10674-10683, 2014
1912014
Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies
A Beck, JM Reichert
MAbs 3 (5), 415-416, 2011
1882011
Forced degradation of recombinant monoclonal antibodies: A practical guide
C Nowak, J K. Cheung, S M. Dellatore, A Katiyar, R Bhat, J Sun, ...
MAbs 9 (8), 1217-1230, 2017
1792017
Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies
A Goyon, M Excoffier, MC Janin-Bussat, B Bobaly, S Fekete, D Guillarme, ...
Journal of Chromatography B 1065, 119-128, 2017
1682017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20